Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents in Subjects With Type 2 Diabetes
Overview[ - collapse ][ - ]
Purpose | to demonstrate the efficacy of inhaled Technosphere/Insulin in combination with metformin versus combination metformin and a secretagogue |
---|---|
Condition | Diabetes Mellitus, Type 2 |
Intervention | Drug: Technosphere Insulin Drug: Metformin & Secretagogues Drug: Technosphere Insulin & Metformin |
Phase | Phase 3 |
Sponsor | Mannkind Corporation |
Responsible Party | Mannkind Corporation |
ClinicalTrials.gov Identifier | NCT00332488 |
First Received | May 31, 2006 |
Last Updated | October 1, 2009 |
Last verified | October 2009 |
Tracking Information[ + expand ][ + ]
First Received Date | May 31, 2006 |
---|---|
Last Updated Date | October 1, 2009 |
Start Date | December 2004 |
Estimated Primary Completion Date | Not Provided |
Current Primary Outcome Measures | Change from baseline to Week 12 in glycated hemoglobin [Time Frame: 12 weeks] [Designated as safety issue: No] |
Current Secondary Outcome Measures | Change in HbA1c from baseline [Time Frame: 24 weeks] [Designated as safety issue: No] |
Descriptive Information[ + expand ][ + ]
Brief Title | Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents in Subjects With Type 2 Diabetes |
---|---|
Official Title | A Phase 3, 24-Week, Multi-Center, Open-Label, Randomized, Controlled Trial Comparing the Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents (Metformin and a Secretagogue) in Subjects With Type 2 Diabetes Mellitus Sub-optimally Controlled on Combination Metformin and a Secretagogue. |
Brief Summary | to demonstrate the efficacy of inhaled Technosphere/Insulin in combination with metformin versus combination metformin and a secretagogue |
Detailed Description | Not Provided |
Study Type | Interventional |
Study Phase | Phase 3 |
Study Design | Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment |
Condition | Diabetes Mellitus, Type 2 |
Intervention | Drug: Technosphere Insulin Inhalation, 15U/30U, prandial Drug: Metformin & Secretagogues Metformin tablets,Secretagogues supplied as any of the currently marketed brands and formulations. Drug: Technosphere Insulin & Metformin Technosphere Insulin Inhalation Powder 15U/30U, Metformin tablets |
Study Arm (s) |
|
Recruitment Information[ + expand ][ + ]
Recruitment Status | Completed |
---|---|
Estimated Enrollment | 547 |
Estimated Completion Date | Not Provided |
Estimated Primary Completion Date | March 2008 |
Eligibility Criteria | Inclusion Criteria: - Non-smokers with clinical diagnosis of Type 2 diabetes mellitus for >or= to 6 months - Stable regimen of metformin for > or = to 1000mg/day 9or maximum tolerated dose) and a secretagogue < or = 1/2 the maximum manufacturer-recommended daily dose without any dose adjustments within the preceding 6 wks. - Fixed dose combination products of metformin and sulfonylurea are acceptable as long as each individual dose meets inclusion criteria - HbA1c >or= to 7.5% and < or= to 11.0% - BMI < or = to 40kg/m2. - FEV1> or = to 70%, Total Lung capacity and > or =80% DLco > or= to 70% Exclusion Criteria: - Treatment with any type of anti-diabetic therapy, other than metformin & secretagogues within the preceding 12 weeks - Serum creatinine > 1.4mg/dL in female subjects and >1.5mg/dL in male subjects - History of chronic obstructive pulmonary disease, clinically proven asthma and/or any other clinically important pulmonary function testing and/or radiologic findings - Evidence of serious complications of diabetes (e.g. autonomic neuropathy) |
Gender | Both |
Ages | 18 Years |
Accepts Healthy Volunteers | No |
Contacts | Not Provided |
Location Countries | United States, Argentina, Brazil, Canada, Chile, Czech Republic, Mexico, Poland, Russian Federation, Spain, Ukraine |
Administrative Information[ + expand ][ + ]
NCT Number | NCT00332488 |
---|---|
Other Study ID Numbers | MKC-TI-103 |
Has Data Monitoring Committee | Not Provided |
Information Provided By | Mannkind Corporation |
Study Sponsor | Mannkind Corporation |
Collaborators | Not Provided |
Investigators | Study Director: Anders Boss Mannkind Corporation |
Verification Date | October 2009 |
Locations[ + expand ][ + ]
Radiant Research-Birmingham | Birmingham, Alabama, United States, 35209 |
---|---|
Parkway Medical Center | Birmingham, Alabama, United States, 35215 |
Redpoint Research | Phoenix, Arizona, United States, 85029 |
Arizona Center for Clinical Research | Phoenix, Arizona, United States, 85032 |
International Clinical Research Network | Chula Vista, California, United States, 91911 |
Jennifer Hone MD | Denver, Colorado, United States, 80220 |
Creekside Endocrine Associates | Denver, Colorado, United States, 80209 |
National Jewish Medical & Research Center | Denver, Colorado, United States, 80206 |
Chase Medical Research, LLC | Waterbury, Connecticut, United States, 06708 |
Center for Diabetes & Endocrine Care | Hollywood, Florida, United States, 33021 |
International Research Associates LLC | Miami, Florida, United States, 33156 |
John H Stoger Jr Hospital of Cook County | Chicago, Illinois, United States, 60612 |
Cedar-Crosse Research Center | Chicago, Illinois, United States, 60607 |
Clintell Inc | Skokie, Illinois, United States, 60076 |
James A Dicke MDPA | Towson, Maryland, United States, 21204 |
East Coast Clinical Research Inc | Haverhill, Massachusetts, United States, 01830 |
Wayne State University | Detroit, Michigan, United States, 48201 |
Michigan Institute of Medicine | Livonia, Michigan, United States, 48152 |
Raidant Research-St Louis | St Louis, Missouri, United States, 63141 |
Clayton Medical Research | St Louis, Missouri, United States, 63117 |
Washington University School of Medicine | St. Louis, Missouri, United States, 63110 |
Creighton Diabetes Center | Omaha, Nebraska, United States, 68131 |
Lovelace Scientific Resources (Albuquerque) | Albuquerque, New Mexico, United States, 87108 |
Winthrop University Hospital | Mineola, New York, United States, 11501 |
North Shore Diabetes and Endocrine Associates | New Hyde Park, New York, United States, 11042 |
Metrolina Internal Medicine | Charlotte, North Carolina, United States, 28204 |
Sensenbrenner Primary Care | Charlotte, North Carolina, United States, 28277 |
Charlotte Clinical Research Inc | Charlotte, North Carolina, United States, 28211 |
Duke Medical Center | Durham, North Carolina, United States, 27710 |
Providence Health Partners - Center of Clinical Research | Dayton, Ohio, United States, 45439 |
Dayton Clinical Research | Dayton, Ohio, United States, 45406 |
Radiant Research | Portland, Oregon, United States, 97239 |
Upstate Pharmaceutical Research | Greenville, South Carolina, United States, 29615 |
Collierville Medical Specialists | Collierville, Tennessee, United States, 38017 |
Memphis Internal Medicine (Kathawala) | Memphis, Tennessee, United States, 38119 |
GoodLife Medical Center PLLC | Memphis, Tennessee, United States, 38120 |
Baylor Endocrine Center | Dallas, Texas, United States, 75246 |
Covenant Clinic Research | San Antonio, Texas, United States, 78229 |
SAM Clinical Research Center | San Antonio, Texas, United States, 78229 |
Quality Assurance Research Center Inc | San Antonio, Texas, United States, 78205 |
Clinical Trials of Texas Inc | San Antonio, Texas, United States, 78229 |
Diabetes & Glandular Disease Research Assoc PA | San Antonio, Texas, United States, 78229 |
Cedar Research | Tacoma, Washington, United States, 98405 |
Hospital Interzonal de Agudos Pedro Fiorito | Avellaneda, Buenos Aires, Argentina, B1870ARG |
Centro Endocrinologic Tiempo | Buenos Aires, Argentina, C1117ABH |
CIMeL | Buenos Aires, Argentina |
Hospital Italiano de Buenos Aires | Buenos Aires, Argentina, C1181ACH |
Cons Asoc de Endocrinologia | Buenos Aires, Argentina, C1425AGC |
Hospital Sao Lucas da PUCRS | Porto Alegre, Rio Grande do Sul, Brazil, 90610-000 |
Hospital de Clinicas de Porto Alegre | Porto Alegre, Rio Grande do Sul, Brazil, 90035-903 |
Ccbr Brasil Centro de Analises e Pesquisas Clinicas Ltda | Rio de Janeiro, Brazil, 22271-100 |
Hospital Guilherme Alvaro | Santos, Brazil, 11045-904 |
Instituto de Pesquisa Clinica e Medicina Avancada | Sao Paulo, Brazil, 05437-010 |
Hospital do Rim e Hipertensao | Sao Paulo, Brazil, 04025-011 |
CPClin-Centro de Pesquisas Clinicas | Sao Paulo, Brazil, 01244-030 |
UNIFRSP | Sao Paulo, Brazil, 04020-050 |
Quest Clinical Trials | Markham, Ontario, Canada, L6B 1A1 |
Lifestyle Metabolism Center | Oakville, Ontario, Canada, L6H 3P1 |
Lifestyle Metabolism Center | Thornhill, Ontario, Canada, L4J 8L7 |
Lifestyle Metabolism Center | Toronto, Ontario, Canada, M4R 2G4 |
Trial Management Group Inc (Henein | Toronto, Ontario, Canada, M4T 1N5 |
Unimedico Management | Richmond Hill, Canada, L4C 9M7 |
Hospital Padre Alberto Hurtado | Santiago, Region Metropolitana, Chile |
Hospital del Salvador | Santiago, Chile |
Instituto de Informacion de Tramiento y Educacion en Salud | Santiago, Chile |
Hospital Clinico Pontificia Universidad Catolica de Chile | Santiago, Chile |
Diabetologicka a interni ambulance | 707 02 Ostrava-Kuncice, CZE, Czech Republic, 70702 |
Institute for Clinical and Exp Medicine | Prague 4, CZE, Czech Republic, 140 21 |
University Hospital Na Bulovce | Prague 8, CZE, Czech Republic, 180 81 |
Diabetologicka ambulance (Chmura) | Ostrava, Czech Republic, 70200 |
Interní a diabetologická Outpatient | Ostrava, Czech Republic, 70900 |
Endokrinologicky ustav | Praha 1, Czech Republic, 11694 |
II interni klinika FN Kralovske Vinohrady | Praha 10, Czech Republic, 10034 |
3rd Medical Department General Faculty Hospital | Praha 2, Czech Republic, 12801 |
Instituto Mexicano de Investigacion | Mexico City, Durango, Mexico, 06700 |
Hospital Universitario Dr Jose E Gonzalez | Monterrey, Nuevo Leon, Mexico, 64460 |
Hospital Santa Engracia-CIMA | Garza Garcia, Mexico, 66260 |
Centro de Estudios en Diabetes | Mexico City, Mexico, 01120 |
Hospital General de Mexico Servicio EndocrinologiaJefe Del Servicio | Mexico City, Mexico, 06726 |
OCA-MIRC | Monterrey, Mexico, 64020 |
Klinika Endocrinologii Diabetologii I | Bialystock, POL, Poland, 15-276 |
NZOZ Specjalistyczny Osrodek Internistyczno - Diabetologiczny | Bialystok, POL, Poland, 15-435 |
Katedra I Klinika Chorob Metabolicznych Collegium Medicum Uniwersytety Jagiellonskiego | Krakow, POL, Poland, 31 501 |
Instytut Centrum Zdrowia (009) Matki Polki | Lodz, POL, Poland, 93-338 |
Spzital Kolejowy imm Wlodzimierza Roeflera | Pruszkow, POL, Poland, 05-800 |
Oddzial Kliniczny Diabetologii (009) Kliniczny nr 1 im Norberta Barlickiego Uniwersytety Meycznego | Lodz, Poland, 90-153 |
Niepubliczny Zaklad Opieki Zdrowotnej VIVAMED | Warsaw, Poland, 03 580 |
Centrum Leczenia Chorob cywilizacyjnych | Warszawa, Poland, 02 777 |
NHI Kemerovo Regional Clinical Hospital | Kemerovo, RUS, Russian Federation, 650061 |
NI Endrocrinological Research Centre of RAMS In patient replacing technologies department | Moscow, RUS, Russian Federation, 115478 |
NI Moscow Regional Scientific Research Clinical Institute na MF Vladimirsky | Moscow, RUS, Russian Federation, 129110 |
NI Principal Military Clinical Hospital n a academician N.N. Burdenko of the Ministry of Defense | Moscow, RUS, Russian Federation, 105229 |
NEI HPE Moscow State University of Medicine and Dentistry of FAHSD City Clinical Hospital #70 | Moscow, RUS, Russian Federation, 111399 |
NEI HPE Smolensk State Medical Academy of FAHSD RNHI Smolensk Regional Clinical Hospital | Smolensk, RUS, Russian Federation, 214018 |
Central Medical Sanitary Unit #122 | St Petersburg, RUS, Russian Federation, 194291 |
St Petersburg NHI City Polytclinic #77 City Diabetological Center #4 | St Petersburg, RUS, Russian Federation, 193012 |
TUV Medico-Military Academy | St Petersburg, RUS, Russian Federation, 198013 |
St Petersburg NHI Municipal Multi-Speciality Hospital # 2 | St. Petersburg, RUS, Russian Federation, 194354 |
NHI Yaroslavl Regional Clinical Hospital | Yaroslavl, RUS, Russian Federation, 150062 |
MHI Clinical Hospital for Emergency Care na NV Soloviev | Yaroslavl, RUS, Russian Federation, 150003 |
NI Central Clinical Hospital of RAS | Moscow, Russian Federation, 117 593 |
Complejo Hospitalario Nuestra Senora de Valme | Sevilla, Andalucia, Spain, 41014 |
Hospital Clinic I Provincial | Barcelona, Spain, 08036 |
Hospital Ramon y Cajal | Madrid, Spain, 28034 |
Hospital Universitario de la Princessa | Madrid, Spain, 28006 |
Corporacion Sanitaria Parc Tauli Unidad de Endocrinologia | Sabadell, Spain, 08208 |
Bukovinian State Medical University Dept of Clinical Immun | Chernivtsy, UKR, Ukraine, 58022 |
Dniepropetrovsh State Medical Academy | Dniepropetrovsk, UKR, Ukraine, 49023 |
Railway Clinical Hospital on Donetsk Station | Donetsk, UKR, Ukraine, 83114 |
Donetsk State Medical University | Donetsk, UKR, Ukraine, 83003 |
Donetsk State Medical University (Chair of Immun Allergogoly & Endocrin) | Donetsk, UKR, Ukraine, 83099 |
Institute of Endocrinology and Metabolism | Kiev, UKR, Ukraine, 04114 |
Chair Family Med of National Med University | Kiev, UKR, Ukraine, 04050 |
Ukr Scientifically Practical Centre of Endocrine Surgery | Kiev, UKR, Ukraine, 2175 |
Odessa Reg. Clinical Hosp Outpatient Department | Odessa, UKR, Ukraine, 65025 |
Odessa State Medical University Dept of Gen Practice and Med Rehab | Odessa, UKR, Ukraine, 65009 |
Odessa State Med Dept of Family Med and Gen Practice | Odessa, UKR, Ukraine, 65039 |
Vinnitsa State Medical University | Vinnitsa, UKR, Ukraine, 21010 |
Outpatient Clinic of Family Physician "Rusanovka" | Kiev, Ukraine, 02147 |
Public Institution City Policlinic #20 Odessa | Odessa, Ukraine, 65114 |